Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes
Objectives Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis‐specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and progno...
Saved in:
| Published in | Journal of cachexia, sarcopenia and muscle Vol. 13; no. 5; pp. 2456 - 2472 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Germany
John Wiley & Sons, Inc
01.10.2022
John Wiley and Sons Inc Wiley |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2190-5991 2190-6009 2190-6009 |
| DOI | 10.1002/jcsm.13045 |
Cover
| Abstract | Objectives
Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis‐specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed.
Methods
Plasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high‐performance liquid chromatography of quadrupole time‐of‐flight mass spectrometry (HPLC‐Q‐TOF‐MS)/MS‐based untargeted metabolomics. Orthogonal partial least‐squares discriminate analysis (OPLS‐DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers.
Results
OPLS‐DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti‐synthetase syndrome (ASS), and immune‐mediated necrotizing myopathy (IMNM)] and MSA‐defined subtypes (anti‐Mi2+, anti‐MDA5+, anti‐TIF1γ+, anti‐Jo1+, anti‐PL7+, anti‐PL12+, anti‐EJ+, and anti‐SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA‐defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti‐EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = −0.416, P = 0.005) and urine malonyl carnitine (r = −0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease.
Conclusions
In both plasma and urine samples, IIM main and MSA‐defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM. |
|---|---|
| AbstractList | Abstract Objectives Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis‐specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed. Methods Plasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high‐performance liquid chromatography of quadrupole time‐of‐flight mass spectrometry (HPLC‐Q‐TOF‐MS)/MS‐based untargeted metabolomics. Orthogonal partial least‐squares discriminate analysis (OPLS‐DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers. Results OPLS‐DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti‐synthetase syndrome (ASS), and immune‐mediated necrotizing myopathy (IMNM)] and MSA‐defined subtypes (anti‐Mi2+, anti‐MDA5+, anti‐TIF1γ+, anti‐Jo1+, anti‐PL7+, anti‐PL12+, anti‐EJ+, and anti‐SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA‐defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti‐EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = −0.416, P = 0.005) and urine malonyl carnitine (r = −0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease. Conclusions In both plasma and urine samples, IIM main and MSA‐defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM. Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis-specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed. Plasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high-performance liquid chromatography of quadrupole time-of-flight mass spectrometry (HPLC-Q-TOF-MS)/MS-based untargeted metabolomics. Orthogonal partial least-squares discriminate analysis (OPLS-DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers. OPLS-DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti-synthetase syndrome (ASS), and immune-mediated necrotizing myopathy (IMNM)] and MSA-defined subtypes (anti-Mi2+, anti-MDA5+, anti-TIF1γ+, anti-Jo1+, anti-PL7+, anti-PL12+, anti-EJ+, and anti-SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA-defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti-EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = -0.416, P = 0.005) and urine malonyl carnitine (r = -0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease. In both plasma and urine samples, IIM main and MSA-defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM. Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis-specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed.OBJECTIVESIdiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis-specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed.Plasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high-performance liquid chromatography of quadrupole time-of-flight mass spectrometry (HPLC-Q-TOF-MS)/MS-based untargeted metabolomics. Orthogonal partial least-squares discriminate analysis (OPLS-DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers.METHODSPlasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high-performance liquid chromatography of quadrupole time-of-flight mass spectrometry (HPLC-Q-TOF-MS)/MS-based untargeted metabolomics. Orthogonal partial least-squares discriminate analysis (OPLS-DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers.OPLS-DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti-synthetase syndrome (ASS), and immune-mediated necrotizing myopathy (IMNM)] and MSA-defined subtypes (anti-Mi2+, anti-MDA5+, anti-TIF1γ+, anti-Jo1+, anti-PL7+, anti-PL12+, anti-EJ+, and anti-SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA-defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti-EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = -0.416, P = 0.005) and urine malonyl carnitine (r = -0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease.RESULTSOPLS-DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti-synthetase syndrome (ASS), and immune-mediated necrotizing myopathy (IMNM)] and MSA-defined subtypes (anti-Mi2+, anti-MDA5+, anti-TIF1γ+, anti-Jo1+, anti-PL7+, anti-PL12+, anti-EJ+, and anti-SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA-defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti-EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = -0.416, P = 0.005) and urine malonyl carnitine (r = -0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease.In both plasma and urine samples, IIM main and MSA-defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM.CONCLUSIONSIn both plasma and urine samples, IIM main and MSA-defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM. ObjectivesIdiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis‐specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed.MethodsPlasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high‐performance liquid chromatography of quadrupole time‐of‐flight mass spectrometry (HPLC‐Q‐TOF‐MS)/MS‐based untargeted metabolomics. Orthogonal partial least‐squares discriminate analysis (OPLS‐DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers.ResultsOPLS‐DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti‐synthetase syndrome (ASS), and immune‐mediated necrotizing myopathy (IMNM)] and MSA‐defined subtypes (anti‐Mi2+, anti‐MDA5+, anti‐TIF1γ+, anti‐Jo1+, anti‐PL7+, anti‐PL12+, anti‐EJ+, and anti‐SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA‐defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti‐EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = −0.416, P = 0.005) and urine malonyl carnitine (r = −0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease.ConclusionsIn both plasma and urine samples, IIM main and MSA‐defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM. Objectives Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on clinical manifestations and myositis‐specific autoantibodies (MSAs). However, even in each IIM subtype, the clinical symptoms and prognoses of patients are very different. Thus, the identification of more potential biomarkers associated with IIM classification, clinical symptoms, and prognosis is urgently needed. Methods Plasma and urine samples from 79 newly diagnosed IIM patients (mean disease duration 4 months) and 52 normal control (NC) samples were analysed by high‐performance liquid chromatography of quadrupole time‐of‐flight mass spectrometry (HPLC‐Q‐TOF‐MS)/MS‐based untargeted metabolomics. Orthogonal partial least‐squares discriminate analysis (OPLS‐DA) were performed to measure the significance of metabolites. Pathway enrichment analysis was conducted based on the KEGG human metabolic pathways. Ten machine learning (ML) algorithms [linear support vector machine (SVM), radial basis function SVM, random forest, nearest neighbour, Gaussian processes, decision trees, neural networks, adaptive boosting (AdaBoost), Gaussian naive Bayes and quadratic discriminant analysis] were used to classify each IIM subtype and select the most important metabolites as potential biomarkers. Results OPLS‐DA showed a clear separation between NC and IIM subtypes in plasma and urine metabolic profiles. KEGG pathway enrichment analysis revealed multiple unique and shared disturbed metabolic pathways in IIM main [dermatomyositis (DM), anti‐synthetase syndrome (ASS), and immune‐mediated necrotizing myopathy (IMNM)] and MSA‐defined subtypes (anti‐Mi2+, anti‐MDA5+, anti‐TIF1γ+, anti‐Jo1+, anti‐PL7+, anti‐PL12+, anti‐EJ+, and anti‐SRP+), such that fatty acid biosynthesis was significantly altered in both plasma and urine in all main IIM subtypes (enrichment ratio > 1). Random forest and AdaBoost performed best in classifying each IIM subtype among the 10 ML models. Using the feature selection methods in ML models, we identified 9 plasma and 10 urine metabolites that contributed most to separate IIM main subtypes and MSA‐defined subtypes, such as plasma creatine (fold change = 3.344, P = 0.024) in IMNM subtype and urine tiglylcarnitine (fold change = 0.351, P = 0.037) in anti‐EJ+ ASS subtype. Sixteen common metabolites were found in both the plasma and urine samples of IIM subtypes. Among them, some were correlated with clinical features, such as plasma hypogeic acid (r = −0.416, P = 0.005) and urine malonyl carnitine (r = −0.374, P = 0.042), which were negatively correlated with the prevalence of interstitial lung disease. Conclusions In both plasma and urine samples, IIM main and MSA‐defined subtypes have specific metabolic signatures and pathways. This study provides useful clues for understanding the molecular mechanisms, searching potential diagnosis biomarkers and therapeutic targets for IIM. |
| Author | Mu, Yibing Guo, Muyao Zhao, Lijuan Li, Liya Zhu, Honglin Liu, Di Jiang, Yu |
| AuthorAffiliation | 5 Department of Rheumatology and Immunology, The Third Xiangya Hospital Central South University Changsha Hunan China 3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha Hunan China 2 Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong China 4 Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Institute of Emergency Medicine Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha Hunan China 6 Department of Nutrition Hunan Provincial Maternal and Child Health Care Hospital Changsha Hunan China 1 Department of Rheumatology and Immunology, Xiangya Hospital Central South University Changsha Hunan China |
| AuthorAffiliation_xml | – name: 1 Department of Rheumatology and Immunology, Xiangya Hospital Central South University Changsha Hunan China – name: 5 Department of Rheumatology and Immunology, The Third Xiangya Hospital Central South University Changsha Hunan China – name: 2 Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong China – name: 6 Department of Nutrition Hunan Provincial Maternal and Child Health Care Hospital Changsha Hunan China – name: 3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha Hunan China – name: 4 Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Institute of Emergency Medicine Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha Hunan China |
| Author_xml | – sequence: 1 givenname: Di surname: Liu fullname: Liu, Di organization: Sun Yat‐sen University – sequence: 2 givenname: Lijuan surname: Zhao fullname: Zhao, Lijuan organization: Central South University – sequence: 3 givenname: Yu surname: Jiang fullname: Jiang, Yu organization: Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University – sequence: 4 givenname: Liya surname: Li fullname: Li, Liya organization: Central South University – sequence: 5 givenname: Muyao surname: Guo fullname: Guo, Muyao organization: Central South University – sequence: 6 givenname: Yibing surname: Mu fullname: Mu, Yibing organization: Hunan Provincial Maternal and Child Health Care Hospital – sequence: 7 givenname: Honglin surname: Zhu fullname: Zhu, Honglin email: honglinzhu@csu.edu.cn organization: Central South University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35860906$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1DAUhiNUREvphgdAkdgg0JTjXOzxBgmNuBQVsaB768Q5aT1y7GAnrcLT45mUilao3tj6_Z1f5_Y8O3DeUZa9ZHDKAIr3Wx37U1ZCVT_JjgomYcUB5MHtu5aSHWYnMW4hnYozXsOz7LCs1xwk8KPs95kb6TLgSG2ODu0cTcx9lw8WY49JavMpGEd5oGtCG_PJmV8T5T2N2Hjre6PzIfjOWIq5cblpjR9wvEqycZ3FvsfRhznv50VOVJyacR4ovsiedsmRTm7v4-zi86eLzdfV-Y8vZ5uP5ytds6peCayo1Z0g0ULRYkdrFNAQaKElQ14Q08CZWOuSsZbEmiMjbDQn7GRTlOVxdrbYth63agimxzArj0btBR8uFYbRaEsKa8FKQgTNdFWhlFBgpYXsqqZtOPLk9W7xmtyA8w1ae2fIQO3moXbzUPt5JPrDQg9T06cayI0B7b0U7v84c6Uu_bWSdQl1JZPBm1uD4FPT46h6EzVZi478FFXBZSHqmkOV0NcP0K2fQhpookQBogKxp179m9FdKn_3IQGwADr4GAN1SpsRR-N3CRr7_yrfPgh5tCVsgW_SwsyPkOrb5uf3JeYP1sPrMQ |
| CitedBy_id | crossref_primary_10_1016_j_metabol_2023_155587 crossref_primary_10_1021_acsomega_4c03111 crossref_primary_10_3390_ijms232415805 crossref_primary_10_1016_j_envpol_2024_125094 crossref_primary_10_1002_cti2_1504 crossref_primary_10_1021_acs_analchem_2c05558 crossref_primary_10_1021_acs_analchem_3c03212 crossref_primary_10_1007_s10278_024_01168_w crossref_primary_10_3389_fnins_2022_1002590 crossref_primary_10_1109_ACCESS_2023_3320798 crossref_primary_10_1093_bib_bbad514 crossref_primary_10_1016_j_trsl_2023_08_001 crossref_primary_10_3389_fimmu_2023_1169057 |
| Cites_doi | 10.1038/nrrheum.2014.2 10.3390/biomedicines8110480 10.1002/mas.21455 10.1016/j.bbrc.2020.02.099 10.1042/BJ20130153 10.1016/j.ymben.2020.06.010 10.1159/000364816 10.1016/j.arr.2018.09.004 10.3389/fendo.2019.00870 10.1111/j.1468-3083.2011.04437.x 10.1002/art.40406 10.1016/j.bbalip.2019.04.003 10.1152/physrev.00035.2018 10.1016/j.biopsych.2010.12.006 10.1038/sj.bjc.6603164 10.1016/j.jacc.2016.06.044 10.1007/s11596-014-1271-7 10.1016/j.cmet.2021.03.025 10.1038/nrrheum.2018.48 10.1093/jnci/djab129 10.1016/j.jnutbio.2005.01.010 10.1007/s11010-016-2688-z 10.1016/j.fct.2020.111594 10.1186/s13075-018-1579-y 10.1093/rheumatology/keaa473 10.1002/art.41733 10.1111/iep.12348 10.1016/j.semarthrit.2020.05.008 10.1021/ac051495j 10.1002/acr.21879 10.1016/j.metabol.2020.154320 10.1016/S1474-4422(18)30254-0 10.1177/1759720X211060907 10.1136/ard.2007.079525 10.1038/s41467‐019‐11129‐5 10.1210/er.2008-0007 10.1016/0009-8981(83)90186-9 10.1016/j.ymgme.2020.07.010 10.1007/s00125-017-4366-4 10.1093/rheumatology/keg084 10.5606/ArchRheumatol.2016.5696 10.3389/fneur.2019.00438 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. – notice: 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1002/jcsm.13045 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Plasma and urine metabolomic profiles in IIM |
| EISSN | 2190-6009 |
| EndPage | 2472 |
| ExternalDocumentID | oai_doaj_org_article_a5713eaa0c1c44a9902a4c79f4bdb6a6 10.1002/jcsm.13045 PMC9530549 35860906 10_1002_jcsm_13045 JCSM13045 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 82101880 – fundername: Natural Science Foundation of Hunan Province funderid: 2020JJ8056 – fundername: National Natural Science Foundation of China grantid: 82101880 – fundername: Natural Science Foundation of Hunan Province grantid: 2020JJ8056 – fundername: ; grantid: 2020JJ8056 – fundername: ; grantid: 82101880 |
| GroupedDBID | --- 0R~ 1OC 24P 2VQ 4.4 40G 53G 5VS 7X7 8FI 8FJ AAHHS AAKDD AAZKR ABUWG ACCFJ ACCMX ACXQS ADBBV ADINQ ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFKRA AHBYD AHSBF AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AOIJS AVUZU AZFZN BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK EBS EJD EMOBN FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH ITC KQ8 M48 M~E O9- OK1 OVD OVEED PIMPY PQQKQ PROAC RPM RSV SMD SOJ U2A UKHRP WIN ZOVNA AAFWJ AAMMB AAYXX AEFGJ AFPKN AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PUEGO CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c5145-7a4edcf7e7d02dafe8a70be0c7c91a62e1c06178c311de786a1eabc6eaf9b233 |
| IEDL.DBID | M48 |
| ISSN | 2190-5991 2190-6009 |
| IngestDate | Fri Oct 03 12:35:43 EDT 2025 Sun Oct 26 04:09:50 EDT 2025 Tue Sep 30 17:19:35 EDT 2025 Thu Sep 04 18:20:11 EDT 2025 Tue Oct 07 07:15:22 EDT 2025 Mon Jul 21 05:57:35 EDT 2025 Thu Apr 24 23:06:16 EDT 2025 Wed Oct 01 03:24:47 EDT 2025 Wed Jan 22 16:24:07 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Idiopathic inflammatory myopathies Biomarkers Metabolomics Machine learning algorithm |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5145-7a4edcf7e7d02dafe8a70be0c7c91a62e1c06178c311de786a1eabc6eaf9b233 |
| Notes | Contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/jcsm.13045 |
| PMID | 35860906 |
| PQID | 2720740704 |
| PQPubID | 4370305 |
| PageCount | 17 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a5713eaa0c1c44a9902a4c79f4bdb6a6 unpaywall_primary_10_1002_jcsm_13045 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9530549 proquest_miscellaneous_2692755604 proquest_journals_2720740704 pubmed_primary_35860906 crossref_citationtrail_10_1002_jcsm_13045 crossref_primary_10_1002_jcsm_13045 wiley_primary_10_1002_jcsm_13045_JCSM13045 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | October 2022 |
| PublicationDateYYYYMMDD | 2022-10-01 |
| PublicationDate_xml | – month: 10 year: 2022 text: October 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Heidelberg – name: Hoboken |
| PublicationTitle | Journal of cachexia, sarcopenia and muscle |
| PublicationTitleAlternate | J Cachexia Sarcopenia Muscle |
| PublicationYear | 2022 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2019; 1864 2021; 6 1983; 134 2017; 60 2006; 94 2013; 27 2006; 78 2013; 65 2019; 99 2019; 10 2020; 61 2016; 31 2020; 525 2020; 145 2020; 101 2018; 20 2021; 73 2018; 48 2020; 8 2021; 13 2018; 17 2014; 4 2021; 33 2017; 36 2016; 416 2020; 131 2020; 50 2021; 114 2008; 29 2011; 70 2018; 70 2008; 67 2013; 454 2021; 60 2020; 111S 2005; 16 2003; 42 2014; 34 2016; 68 2018; 14 2014; 10 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Anupam G (e_1_2_7_11_1) 2021; 6 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 |
| References_xml | – volume: 68 start-page: 1281 year: 2016 end-page: 1293 article-title: Comprehensive metabolomic characterization of coronary artery diseases publication-title: J Am Coll Cardiol – volume: 73 start-page: 1738 year: 2021 end-page: 1748 article-title: Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout publication-title: Arthritis Rheumatol – volume: 42 start-page: 298 year: 2003 end-page: 303 article-title: Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis publication-title: Rheumatology (Oxford) – volume: 145 year: 2020 article-title: The lysine derivative aminoadipic acid, a biomarker of protein oxidation and diabetes‐risk, induces production of reactive oxygen species and impairs trypsin secretion in mouse pancreatic acinar cells publication-title: Food Chem Toxicol – volume: 33 start-page: 905 year: 2021 end-page: 922 article-title: The adverse metabolic effects of branched‐chain amino acids are mediated by isoleucine and valine publication-title: Cell Metab – volume: 48 start-page: 51 year: 2018 end-page: 78 article-title: Significance of urinary 11‐dehydro‐thromboxane B2 in age‐related diseases: Focus on atherothrombosis publication-title: Ageing Res Rev – volume: 10 start-page: 295 year: 2014 end-page: 303 article-title: The skeletal muscle arachidonic acid cascade in health and inflammatory disease publication-title: Nat Rev Rheumatol – volume: 10 year: 2019 article-title: Decreases in circulating concentrations of long‐chain acylcarnitines and free fatty acids during the glucose tolerance test represent tissue‐specific insulin sensitivity publication-title: Front Endocrinol (Lausanne) – volume: 65 start-page: 793 year: 2013 end-page: 799 article-title: Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease publication-title: Arthritis Care Res (Hoboken) – volume: 99 start-page: 1819 year: 2019 end-page: 1875 article-title: Metabolomics for investigating physiological and pathophysiological processes publication-title: Physiol Rev – volume: 16 start-page: 375 year: 2005 end-page: 382 article-title: Moderate intake of myristic acid in sn‐2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study publication-title: J Nutr Biochem – volume: 10 year: 2019 article-title: Glycine, serine and threonine metabolism confounds efficacy of complement‐mediated killing publication-title: Nat Commun – volume: 6 start-page: 515 year: 2021 end-page: 526 article-title: NMR‐based serum and muscle metabolomics for diagnosis and activity assessment in idiopathic inflammatory myopathies publication-title: Anal Sci Adv – volume: 4 start-page: 252 year: 2014 end-page: 262 article-title: Serum metabolomic biomarkers of dementia publication-title: Dement Geriatr Cogn Dis Extra – volume: 36 start-page: 115 year: 2017 end-page: 134 article-title: Mass spectrometric based approaches in urine metabolomics and biomarker discovery publication-title: Mass Spectrom Rev – volume: 416 start-page: 11 year: 2016 end-page: 22 article-title: Mitochondrial defects associated with beta‐alanine toxicity: relevance to hyper‐beta‐alaninemia publication-title: Mol Cell Biochem – volume: 454 start-page: 91 year: 2013 end-page: 99 article-title: Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate publication-title: Biochem J – volume: 134 start-page: 77 year: 1983 end-page: 83 article-title: Isovalerylglucuronide, a new urinary metabolite in isovaleric acidemia. Identification problems due to rearrangement reactions publication-title: Clin Chim Acta – volume: 17 start-page: 816 year: 2018 end-page: 828 article-title: Classification and management of adult inflammatory myopathies publication-title: Lancet Neurol – volume: 27 start-page: 175 year: 2013 end-page: 179 article-title: Lipid profiles in untreated patients with dermatomyositis publication-title: J Eur Acad Dermatol Venereol – volume: 34 start-page: 276 year: 2014 end-page: 283 article-title: A HPLC‐Q‐TOF‐MS‐based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome publication-title: J Huazhong Univ Sci Technolog Med Sci – volume: 14 start-page: 255 year: 2018 end-page: 268 article-title: Risk factors and disease mechanisms in myositis publication-title: Nat Rev Rheumatol – volume: 60 start-page: 2177 year: 2021 end-page: 2189 article-title: PKM2‐dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis/polymyositis publication-title: Rheumatology (Oxford) – volume: 50 start-page: 627 year: 2020 end-page: 635 article-title: The altered metabolism profile in pathogenesis of idiopathic inflammatory myopathies publication-title: Semin Arthritis Rheum – volume: 31 start-page: 133 year: 2016 end-page: 138 article-title: Screening of free carnitine and acylcarnitine status in children with familial Mediterranean fever publication-title: Arch Rheumatol – volume: 78 start-page: 567 year: 2006 end-page: 574 article-title: Large‐scale human metabolomics studies: a strategy for data (pre‐) processing and validation publication-title: Anal Chem – volume: 61 start-page: 225 year: 2020 end-page: 237 article-title: Pyruvate metabolism redirection for biological production of commodity chemicals in aerobic fungus publication-title: Metab Eng – volume: 60 start-page: 2076 year: 2017 end-page: 2083 article-title: Chronic administration of myristic acid improves hyperglycaemia in the Nagoya‐Shibata‐Yasuda mouse model of congenital type 2 diabetes publication-title: Diabetologia – volume: 29 start-page: 647 year: 2008 end-page: 676 article-title: Glycerolipid metabolism and signaling in health and disease publication-title: Endocr Rev – volume: 20 start-page: 83 year: 2018 article-title: Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis publication-title: Arthritis Res Ther – volume: 114 start-page: 123 year: 2021 end-page: 129 article-title: Urinary thromboxane B2 and lethal prostate cancer in African American men publication-title: J Natl Cancer Inst – volume: 1864 start-page: 1031 year: 2019 end-page: 1038 article-title: Myristic acid specifically stabilizes diacylglycerol kinase delta protein in C2C12 skeletal muscle cells publication-title: Biochim Biophys Acta Mol Cell Biol Lipids – volume: 525 start-page: 406 year: 2020 end-page: 411 article-title: Oleic acid up‐regulates myosin heavy chain (MyHC) 1 expression and increases mitochondrial mass and maximum respiration in C2C12 myoblasts publication-title: Biochem Biophys Res Commun – volume: 111S year: 2020 article-title: The role of omics in the pathophysiology, diagnosis and treatment of non‐alcoholic fatty liver disease publication-title: Metabolism – volume: 94 start-page: 1726 year: 2006 end-page: 1733 article-title: Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control publication-title: Br J Cancer – volume: 101 start-page: 55 year: 2020 end-page: 64 article-title: Anti‐inflammatory effect of omega unsaturated fatty acids and dialysable leucocyte extracts on collagen‐induced arthritis in DBA/1 mice publication-title: Int J Exp Pathol – volume: 13 year: 2021 article-title: Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease publication-title: Ther Adv Musculoskelet Dis – volume: 70 start-page: 175 year: 2011 end-page: 182 article-title: Chronic low‐grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms publication-title: Biol Psychiatry – volume: 67 start-page: 1596 year: 2008 end-page: 1602 article-title: Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis publication-title: Ann Rheum Dis – volume: 70 start-page: 637 year: 2018 end-page: 652 article-title: The tumor‐like phenotype of rheumatoid synovium: Molecular profiling and prospects for precision medicine publication-title: Arthritis Rheumatol – volume: 131 start-page: 14 year: 2020 end-page: 22 article-title: The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies publication-title: Mol Genet Metab – volume: 8 year: 2020 article-title: Release of anti‐inflammatory palmitoleic acid and its positional isomers by mouse peritoneal macrophages publication-title: Biomedicine – volume: 10 year: 2019 article-title: Disease specific autoantibodies in idiopathic inflammatory myopathies publication-title: Front Neurol – ident: e_1_2_7_29_1 doi: 10.1038/nrrheum.2014.2 – ident: e_1_2_7_34_1 doi: 10.3390/biomedicines8110480 – ident: e_1_2_7_12_1 doi: 10.1002/mas.21455 – ident: e_1_2_7_28_1 doi: 10.1016/j.bbrc.2020.02.099 – ident: e_1_2_7_14_1 doi: 10.1042/BJ20130153 – ident: e_1_2_7_36_1 doi: 10.1016/j.ymben.2020.06.010 – ident: e_1_2_7_26_1 doi: 10.1159/000364816 – ident: e_1_2_7_23_1 doi: 10.1016/j.arr.2018.09.004 – ident: e_1_2_7_30_1 doi: 10.3389/fendo.2019.00870 – ident: e_1_2_7_37_1 doi: 10.1111/j.1468-3083.2011.04437.x – ident: e_1_2_7_10_1 doi: 10.1002/art.40406 – ident: e_1_2_7_17_1 doi: 10.1016/j.bbalip.2019.04.003 – ident: e_1_2_7_8_1 doi: 10.1152/physrev.00035.2018 – ident: e_1_2_7_38_1 doi: 10.1016/j.biopsych.2010.12.006 – ident: e_1_2_7_33_1 doi: 10.1038/sj.bjc.6603164 – ident: e_1_2_7_44_1 doi: 10.1016/j.jacc.2016.06.044 – ident: e_1_2_7_32_1 doi: 10.1007/s11596-014-1271-7 – ident: e_1_2_7_41_1 doi: 10.1016/j.cmet.2021.03.025 – ident: e_1_2_7_22_1 doi: 10.1038/nrrheum.2018.48 – ident: e_1_2_7_24_1 doi: 10.1093/jnci/djab129 – ident: e_1_2_7_15_1 doi: 10.1016/j.jnutbio.2005.01.010 – ident: e_1_2_7_21_1 doi: 10.1007/s11010-016-2688-z – volume: 6 start-page: 515 year: 2021 ident: e_1_2_7_11_1 article-title: NMR‐based serum and muscle metabolomics for diagnosis and activity assessment in idiopathic inflammatory myopathies publication-title: Anal Sci Adv – ident: e_1_2_7_20_1 doi: 10.1016/j.fct.2020.111594 – ident: e_1_2_7_6_1 doi: 10.1186/s13075-018-1579-y – ident: e_1_2_7_7_1 doi: 10.1093/rheumatology/keaa473 – ident: e_1_2_7_9_1 doi: 10.1002/art.41733 – ident: e_1_2_7_27_1 doi: 10.1111/iep.12348 – ident: e_1_2_7_5_1 doi: 10.1016/j.semarthrit.2020.05.008 – ident: e_1_2_7_43_1 doi: 10.1021/ac051495j – ident: e_1_2_7_35_1 doi: 10.1002/acr.21879 – ident: e_1_2_7_13_1 doi: 10.1016/j.metabol.2020.154320 – ident: e_1_2_7_2_1 doi: 10.1016/S1474-4422(18)30254-0 – ident: e_1_2_7_3_1 doi: 10.1177/1759720X211060907 – ident: e_1_2_7_25_1 doi: 10.1136/ard.2007.079525 – ident: e_1_2_7_40_1 doi: 10.1038/s41467‐019‐11129‐5 – ident: e_1_2_7_42_1 doi: 10.1210/er.2008-0007 – ident: e_1_2_7_19_1 doi: 10.1016/0009-8981(83)90186-9 – ident: e_1_2_7_39_1 doi: 10.1016/j.ymgme.2020.07.010 – ident: e_1_2_7_16_1 doi: 10.1007/s00125-017-4366-4 – ident: e_1_2_7_18_1 doi: 10.1093/rheumatology/keg084 – ident: e_1_2_7_31_1 doi: 10.5606/ArchRheumatol.2016.5696 – ident: e_1_2_7_4_1 doi: 10.3389/fneur.2019.00438 |
| SSID | ssj0000461650 |
| Score | 2.3726895 |
| Snippet | Objectives
Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes... Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based on... ObjectivesIdiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different subtypes based... Abstract Objectives Idiopathic inflammatory myopathies (IIM) are a class of autoimmune diseases with high heterogeneity that can be divided into different... |
| SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2456 |
| SubjectTerms | Algorithms Autoantibodies Autoimmune diseases Bayes Theorem Biomarkers Carnitine Chromatography Creatine Discriminant analysis Disease Fatty Acids Humans Idiopathic inflammatory myopathies Machine learning Machine learning algorithm Metabolism Metabolites Metabolomics Myositis - diagnosis Original Plasma Software Support vector machines Urine |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLbQDsAF8ZvCQEbsAlI0J3Hs-AgT05hULgxpN-v5lyhq0mpphMZfz7OTRq2YxoVb67xWyXuf7c-x3_cIOeLM1w5JW1b73GfclmUG0pmsxJVYFXDKdjzmDs-_irPv_Pyyutwp9RXPhA3ywIPjjqHCZZQHYDa3nAMOngVwK1XgxhkBSWyb1WpnMZXGYC5ykcqzFjFXukIWNGmTFsc_bdfEMsgxh2lnNkqi_Tcxzb8PTN7r2zVc_4Llcp_Uplnp9CF5MNJJ-nF4jEfkjm8fk7vzccP8Cfn9ZSsH4SiM-iN0FegaSXMD2ORofN3uaVRyQiTSPgm60sZvEB3LmLJMx7LeHV20dOEWq1TE2OK3gGhq0i49ba6HZrTqehPf63ZPycXp54uTs2wst5BZZE1VJoHjEwbppWOFg-BrkMx4ZqVVOYjC5zbyndqWee68rAXkHowVHoIyRVk-IwftqvUvCLVWeYlExJYmcMWFcfirGlxuMX4iqBl5v_W6tqMUeayIsdSDiHKhY4R0itCMvJts14MAx41Wn2LwJosomp0aEEp6hJL-F5Rm5HAbej325E7HfWqJq17GZ-TtdBn7YNxYgdaverQRqpAVcke0eT4gZbqTsqoFUwz_XO5haO9W96-0ix9J51tVOBhz9NbRhLZbXfAhAfEWE31-8m2ePr38H_56Re4XMRkkHW08JAebq96_Roq2MW9Sb_wDcZA9DA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZGJwEviDuFgYzYC0jRcnHs5AEhNm0ak1ohGNLeohPbGUVNUpZGaPx6znEuUDH1rXVOK8c-tj_7-HwfY_vCt4lB0OYlNrCe0FHkgTK5F-FOLC5wyTaCcodnc3n6TZxdxBc7bD7kwtC1ymFOdBO1qTWdkR9QvFDh7sMXH1Y_PVKNoujqIKEBvbSCee8oxm6x3ZCYsSZs9_B4_vnLeOpC9OLSybaGlEMdIzoaOUvDgx-6KUkemXKb_lmlHJn_TQj0_4uUd9pqBde_YLncBLtutTq5z-71MJN_7PziAdux1UN2e9YH0h-x358GmgjDoecl4XXBVwimS8Aiw-kY3nJieEIP5a0jeuWlXaPXLCmVmfdy3w1fVHxhFrUTN9b4rUAvK130npfXXTFaNW1O573NY3Z-cnx-dOr1MgyeRjQVewoEvmGhrDJ-aKCwCSg_t75WOg1AhjbQhIMSHQWBsSqREFjItbRQpHkYRU_YpKor-4xxrVOrEKDoKC9EKmRu8FcJmEADbruKdMreDq2e6Z6inJQylllHrhxm1EOZ66EpezParjpijhutDqnzRgsi03YF9dVl1o_NDGLcqVsAXwdaCKyKH4LQKi1EbnIJcsr2hq7P-hHeZH_9ccpej49xbFLABSpbt2gj01DFiCnR5mnnKWNNojiRfurjn6sNH9qo6uaTavHd8X-nMU7SAltrf_S2rU3wzjniFpPs7OjrzH16vv1VX7C7IaV_uMuMe2yyvmrtSwRl6_xVP9L-APaOOkE priority: 102 providerName: ProQuest – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELZgKwEv3MdCQUb0BaSUHI4dP5aKqlTaColWKk_R-Ahsu0lWzUao_fWMnWzUQFUh8ZZ1JpHj_cb-fMw3hGyx0GYGSVuQ2cgGTCdJAMKoIMGZWFrgkG2Yix2eHfL9Y3Zwkp5cieLv9CGGBTfnGb6_dg6-NEXXz_e7-_HHU92ULp8xS2-TDZ4iG5-QjePDrzvfXU45FyWdSp80z1_j2C4HhdKrD4_GJC_dfx3f_PvY5N22WsLFL1gsxtTWj017Dwisv6o7knK23a7Utr78Q_Dxfz77IbnfE1e60yHtEbllq8fkzqzfmn9CLr-shScMhV7phNYFXSI9LwGLDHUL-5Y6zSjEPG29dCwt7QpxuHDB0bRPIN7QeUXnZl77dMkafxWI29KfB6DlRVeMVk2r3Apy85Qc7X0-2t0P-sQOgUZ-lgYCGLZiIawwYWygsBmIUNlQCy0j4LGNtGNWmU6iyFiRcYgsKM0tFFLFSfKMTKq6si8I1VpagZRHJ6pgknFl8KkMTKQBJ3KFnJL36382173oucu9scg7ueY4d22Z-7ackneD7bKT-rjW6pMDyGDh5Ll9QX3-I--9PYcU5_4WINSRZgyrEsbAtJAFU0Zx4FOyuYZX3vcZTe52xAXOr0M2JW-H2-jtbgsHKlu3aMNlLFJkqWjzvEPjUJMkzXgoQ3y5GOF0VNXxnWr-0yuKyxS7fYattTUg-sYm-OAReoNJfrD7beavXv7bO1-Re7ELLPHHJDfJZHXe2tdI91bqTe_RvwGQXVj6 priority: 102 providerName: Unpaywall – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9UwFA5zgvoi_vbqlIh7UShr0zRpwRcdjjm4Ijhhb-XkR-eV2_ay3iLzr_ectLfj4hj41qanJU2-03xJer7D2L6Mfe6QtEW5T3wkbZpGoJ2JUpyJZRUO2U5S7PD8qzr-IU_OsrMd9mETCzPoQ0wLbuQZ4XtNDg6mO7gSDf1lu5pyGcvsFrudIJEhfAv5bVphISlxFVK0CoqXzpAJTfqk4uDq9q0RKQj3X8c2__1p8m7frODyNyyX28Q2jExHD9j9kVLyjwMGHrId3zxid-bjpvlj9ufLRhLCcRg1SHhb8RUS5xqwyHFacvec1JwQjbwPoq689mtEyJLClvmY2rvji4Yv3KINiYwtnlWIqDrs1PP6cihGq643tLbbPWGnR59PD4-jMeVCZJE5ZZEGiW9Yaa9dLBxUPgcdGx9bbYsElPCJJc6T2zRJnNe5gsSDscpDVRiRpk_ZbtM2_jnj1hZeIxmxqalkIZVxeFcOLrGAU6yqmLF3m1Yv7ShHTlkxluUgpCxK6qEy9NCMvZ1sV4MIx7VWn6jzJgsSzg4F7cV5OfphCRnOyj1AbBMrJVYlFiCtLippnFGgZmxv0_Xl6M1dSXvVGme-sZyxN9Nl9EPaXIHGtz3aqELoDPkj2jwbkDLVJM1yFRcxPlxvYWirqttXmsXPoPVdZPhBltha-xPabmyC9wGIN5iUJ4ff5-Hoxf8Yv2T3BAV-hN8Y99ju-qL3r5COrc3r4HV_AeJfNPc priority: 102 providerName: Wiley-Blackwell |
| Title | Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcsm.13045 https://www.ncbi.nlm.nih.gov/pubmed/35860906 https://www.proquest.com/docview/2720740704 https://www.proquest.com/docview/2692755604 https://pubmed.ncbi.nlm.nih.gov/PMC9530549 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcsm.13045 https://doaj.org/article/a5713eaa0c1c44a9902a4c79f4bdb6a6 |
| UnpaywallVersion | publishedVersion |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: KQ8 dateStart: 20100101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: KQ8 dateStart: 20100901 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: GX1 dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 7X7 dateStart: 20100901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: BENPR dateStart: 20100901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2190-6009 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: M48 dateStart: 20100901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Open Access Hybrid - NESLI2 2011-2012 customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 40G dateStart: 20100101 isFulltext: true titleUrlDefault: http://link.springer.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: U2A dateStart: 20100901 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: AVUZU dateStart: 20100901 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 24P dateStart: 20100101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBf9gK0vY9_L1gWNlcEG3vwhS_bDGG1p6QoJYWsgezKyJG8psZ3GMVv21-8ky2ZmoewlJPLFyKeT73c66XcIHRFXRRJAmxMpTzlEBIHDmUydACKxMAOXLYk-Ozwa04spuZyFsx3UbmK3Cqy2hna6ntR0tXj_62bzCSb8R0sg-uFaVLmuakzCN8sbRxeU0olXW11jF-2D04p1VYeRRf7mJU2oR039Vl8fpga3H3fkpX_fseeuDKv_Nij6747Ku3Wx5JuffLHoo17jts7vo3sWb-LjxkAeoB1VPER3Rjaj_gj9_tzyRUjMLUEJLjO8BFSdc2iSWK_HK6ypnkBluDaMrzhXazCfhT7TjG3d7wrPCzyX89JUORbwKwNzy00aH-ebphmkqjrVC7_VY3R1fnZ1euHYegyOAFgVOowTeMKMKSZdX_JMRZy5qXIFE7HHqa88oQFRJALPk4pFlHuKp4IqnsWpHwRP0F5RFuoZwkLEigFSEUGakZjQVMK_Ii49wSH-yuIBettqPRGWq1yXzFgkDcuyn-gRSswIDdDrTnbZMHRslTrRg9dJaFZt01Cuvid2kiY8hJBdce4KTxACXXF9TgSLM5LKlHI6QIft0CetpSY6kc0gLHbJAL3qLsMk1ZkXXqiyBhka-ywEcAkyTxtL6XoShBEF-4Sbs54N9brav1LMfxgi8DiEtzUBbR111narCt4ZQ7xFJLk8_Toy357_x7O8QAe-PgxitjYeor31qlYvAaKt0yHa9ckEPtmMDdH-ydl48mVoljuGZhpC23Q8Of72B-6vRX0 |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTWK8IL7pGGDEeAApWuI4cfIwITY2tdtaISjS3izHdqBTm5Sl1VT-N_437twkUDH1bW-tc60c3_m-7PsdIXvct4kBp81LbGA9rsPQU8JkXgiRWJSDyTYca4f7g7j7jZ9eRBcb5HdTC4PXKhud6BS1KTXmyPfxvFBA9OHzD9OfHnaNwtPVpoWGqlsrmAMHMVYXdpzZxTWEcNVB7xPw-y1jJ8fDo65XdxnwNDgLkScUt0bnwgrjM6NymyjhZ9bXQqeBipkNNJr5RIdBYKxIYhVYlenYqjzNGOZDwQJs8ZCnEPttHR4PPn9pkzyIZh67LrEMS7YjcMZaiFS2f6mrCXZjxlKqf4yi6x1wk8P7_73N7XkxVYtrNR6v-tbOOJ7cJ_dqr5Z-XIrhA7Jhi4fkTr8-t39EfvUaVApDVQ2DQsucTsF3nygYMhSz_pYioBRsCDp3uLJ0YmcgpGOsnKZ1d_GKjgo6MqPS9VLW8C0HoZ64ywJ0slgOA1U1zzC9XD0mw9vgxxOyWZSFfUao1qkV4A_pMMt5yuPMwK8SZQKtIMrL0w5516y61DUiOjbmGMslljOTyCHpONQhb1ra6RIH5EaqQ2ReS4HY3W6gvPoua1UgVSSC0Crl60BzDlPxmeJapDnPTBaruEN2G9bLWqFU8q_4d8jr9jGoAjzfUYUt50ATp0xE4MICzdOlpLQzCaMk9lMf_lysyNDKVFefFKMfDm48jcAmcFitvVba1i7BeyeIa0jk6dHXvvu0s_5VX5Ht7rB_Ls97g7Pn5C7DyhN3j3KXbM6u5vYF-IOz7GW96yiRt7zP_wBk5niV |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIQ1eEN_rGGDEeAApauI4cfKAEGxU60YnJIbUN8uxHShqk25pNZX_jP-OO-cDKqa-7a11rpXjO9-dz3e_I-SA-zYx4LR5iQ2sx3UYekqYzAvhJBblYLINx9rh0Vl8_I2fjKPxFvnd1sJgWmWrE52iNqXGGHkf7wsFnD583s-btIgvR4P38wsPO0jhTWvbTqMWkVO7uoLjW_VueAS8fs3Y4NP54bHXdBjwNDgKkScUt0bnwgrjM6NymyjhZ9bXQqeBipkNNJr4RIdBYKxIYhVYlenYqjzNGMZCQfvfEmGYYjahGIsuvIM45rHrD8uwWDsCN6wDR2X9n7qaYR9mLKL6xxy6rgHXubr_Z2zeXhZztbpS0-m6V-3M4uAeudv4s_RDLYD3yZYtHpCdUXNj_5D8GrZ4FIaqBgCFljmdg9c-UzBkKMb7LUUoKdgKdOkQZenMLkA8p1gzTZu-4hWdFHRiJqXroqzhWw7iPHNpAnS2qoeBqlpmGFiuHpHzm-DGY7JdlIXdJVTr1ArwhHSY5TzlcWbgV4kygVZwvsvTHnnTrrrUDRY6tuSYyhrFmUnkkHQc6pFXHe28RgC5luojMq-jQNRuN1BefpeNEpAqEkFolfJ1oDmHqfhMcS3SnGcmi1XcI_st62WjSir5V_B75GX3GJQA3uyowpZLoIlTJiJwXoHmSS0p3UzCKIn91Ic_F2sytDbV9SfF5IcDGk8jsAYcVuugk7aNS_DWCeIGEnly-HXkPu1tftUXZAd2t_w8PDt9Su4wLDlxCZT7ZHtxubTPwBFcZM_dlqNE3vAW_wMwaHYv |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELZgKwEv3MdCQUb0BaSUHI4dP5aKqlTaColWKk_R-Ahsu0lWzUao_fWMnWzUQFUh8ZZ1JpHj_cb-fMw3hGyx0GYGSVuQ2cgGTCdJAMKoIMGZWFrgkG2Yix2eHfL9Y3Zwkp5cieLv9CGGBTfnGb6_dg6-NEXXz_e7-_HHU92ULp8xS2-TDZ4iG5-QjePDrzvfXU45FyWdSp80z1_j2C4HhdKrD4_GJC_dfx3f_PvY5N22WsLFL1gsxtTWj017Dwisv6o7knK23a7Utr78Q_Dxfz77IbnfE1e60yHtEbllq8fkzqzfmn9CLr-shScMhV7phNYFXSI9LwGLDHUL-5Y6zSjEPG29dCwt7QpxuHDB0bRPIN7QeUXnZl77dMkafxWI29KfB6DlRVeMVk2r3Apy85Qc7X0-2t0P-sQOgUZ-lgYCGLZiIawwYWygsBmIUNlQCy0j4LGNtGNWmU6iyFiRcYgsKM0tFFLFSfKMTKq6si8I1VpagZRHJ6pgknFl8KkMTKQBJ3KFnJL36382173oucu9scg7ueY4d22Z-7ackneD7bKT-rjW6pMDyGDh5Ll9QX3-I--9PYcU5_4WINSRZgyrEsbAtJAFU0Zx4FOyuYZX3vcZTe52xAXOr0M2JW-H2-jtbgsHKlu3aMNlLFJkqWjzvEPjUJMkzXgoQ3y5GOF0VNXxnWr-0yuKyxS7fYattTUg-sYm-OAReoNJfrD7beavXv7bO1-Re7ELLPHHJDfJZHXe2tdI91bqTe_RvwGQXVj6 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integrated+analysis+of+plasma+and+urine+reveals+unique+metabolomic+profiles+in+idiopathic+inflammatory+myopathies+subtypes&rft.jtitle=Journal+of+cachexia%2C+sarcopenia+and+muscle&rft.au=Liu%2C+Di&rft.au=Zhao%2C+Lijuan&rft.au=Jiang%2C+Yu&rft.au=Li%2C+Liya&rft.date=2022-10-01&rft.issn=2190-6009&rft.eissn=2190-6009&rft.volume=13&rft.issue=5&rft.spage=2456&rft_id=info:doi/10.1002%2Fjcsm.13045&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2190-5991&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2190-5991&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2190-5991&client=summon |